March R - Search Results

1

Interstitial lung disease in gefitinib-treated Japanese patients with non-small-cell lung cancer: genome-wide analysis of genetic data.

Nyberg F, Barratt BJ, Mushiroda T, Takahashi A, Jawaid A, Hada S, Umemura T, Fukuoka M, Nakata K, Ohe Y, Kato H, Kudoh S, March R, Nakamura Y, Kamatani N. Nyberg F, et al. Among authors: march r. Pharmacogenomics. 2011 Jul;12(7):965-75. doi: 10.2217/pgs.11.38. Pharmacogenomics. 2011. PMID: 21787189

2

Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis.

Kindmark A, Jawaid A, Harbron CG, Barratt BJ, Bengtsson OF, Andersson TB, Carlsson S, Cederbrant KE, Gibson NJ, Armstrong M, Lagerström-Fermér ME, Dellsén A, Brown EM, Thornton M, Dukes C, Jenkins SC, Firth MA, Harrod GO, Pinel TH, Billing-Clason SM, Cardon LR, March RE. Kindmark A, et al. Among authors: march re. Pharmacogenomics J. 2008 Jun;8(3):186-95. doi: 10.1038/sj.tpj.6500458. Epub 2007 May 15. Pharmacogenomics J. 2008. PMID: 17505501

3

Novel technology and the development of pharmacogenetics within the pharmaceutical industry.

Gibson N, Jawaid A, March R. Gibson N, et al. Among authors: march r. Pharmacogenomics. 2005 Jun;6(4):339-56. doi: 10.1517/14622416.6.4.339. Pharmacogenomics. 2005. PMID: 16004553 Review.

4

Selecting cases from nuclear families for case-control association analysis.

Moore RM, Pinel T, Zhao JH, March R, Jawaid A. Moore RM, et al. Among authors: march r. BMC Genet. 2005 Dec 30;6 Suppl 1(Suppl 1):S105. doi: 10.1186/1471-2156-6-S1-S105. BMC Genet. 2005. PMID: 16451561 Free PMC article.

5

Gene mapping strategies for complex disease and drug response.

Jawaid A, Moore R, March R, Barratt BJ. Jawaid A, et al. Among authors: march r. Drug Discov Today Technol. 2006 Summer;3(2):131-6. doi: 10.1016/j.ddtec.2006.06.003. Drug Discov Today Technol. 2006. PMID: 24980399

6

Serious carbamazepine-induced hypersensitivity reactions associated with the HSP70 gene cluster.

Alfirevic A, Mills T, Harrington P, Pinel T, Sherwood J, Jawaid A, Smith JC, March RE, Barratt BJ, Chadwick DW, Kevin Park B, Pirmohamed M. Alfirevic A, et al. Pharmacogenet Genomics. 2006 Apr;16(4):287-96. doi: 10.1097/01.fpc.0000189800.88596.7a. Pharmacogenet Genomics. 2006. PMID: 16538175

7

Pharmacogenetics--legal, ethical and regulatory considerations.

March R, Cheeseman K, Doherty M. March R, et al. Pharmacogenomics. 2001 Nov;2(4):317-27. doi: 10.1517/14622416.2.4.317. Pharmacogenomics. 2001. PMID: 11722282 Review.

8

Gene mapping by linkage and association analysis.

March RE. March RE. Mol Biotechnol. 1999 Dec 1;13(2):113-22. doi: 10.1385/MB:13:2:113. Mol Biotechnol. 1999. PMID: 10934526 Review.

9

Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework.

Cook D, Brown D, Alexander R, March R, Morgan P, Satterthwaite G, Pangalos MN. Cook D, et al. Among authors: march r. Nat Rev Drug Discov. 2014 Jun;13(6):419-31. doi: 10.1038/nrd4309. Epub 2014 May 16. Nat Rev Drug Discov. 2014. PMID: 24833294 Review.

10

Automation and validation of DNA-banking systems.

Thornton M, Gladwin A, Payne R, Moore R, Cresswell C, McKechnie D, Kelly S, March R. Thornton M, et al. Among authors: march r. Drug Discov Today. 2005 Oct 15;10(20):1369-75. doi: 10.1016/S1359-6446(05)03560-9. Drug Discov Today. 2005. PMID: 16253875 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters